Literature DB >> 19841876

Stem cells--meet immunity.

Tracy S P Heng1, Jarrod A Dudakov, Danika M P Khong, Ann P Chidgey, Richard L Boyd.   

Abstract

The ability of stem cells to differentiate into various different cell types holds great promise for the treatment of irreversible tissue damage that occurs in many debilitating conditions. With stem cell research advancing at a tremendous pace, it is becoming clear that one of the greatest hurdles to successful stem cell-derived therapies is overcoming immune rejection of the transplant. Although the use of immunosuppressive drugs can decrease the incidence of acute graft rejection, the burden of problems associated with prolonged immunosuppression must be reduced. Strategies inducing specific immunological tolerance complemented by enhanced immune function will bring stem cell therapies closer to reality.

Mesh:

Year:  2009        PMID: 19841876     DOI: 10.1007/s00109-009-0539-z

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  82 in total

Review 1.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

Review 2.  Stems cells and the pathways to aging and cancer.

Authors:  Derrick J Rossi; Catriona H M Jamieson; Irving L Weissman
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

3.  Ablation and regeneration of tolerance-inducing medullary thymic epithelial cells after cyclosporine, cyclophosphamide, and dexamethasone treatment.

Authors:  Anne L Fletcher; Tamara E Lowen; Samy Sakkal; Jessica J Reiseger; Maree V Hammett; Natalie Seach; Hamish S Scott; Richard L Boyd; Ann P Chidgey
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

Review 4.  Stromal stem cells: marrow-derived osteogenic precursors.

Authors:  M Owen; A J Friedenstein
Journal:  Ciba Found Symp       Date:  1988

5.  Human adipose tissue is a source of multipotent stem cells.

Authors:  Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells.

Authors:  Simona W Rossi; Lukas T Jeker; Tomoo Ueno; Sachiyo Kuse; Marcel P Keller; Saulius Zuklys; Andrei V Gudkov; Yousuke Takahama; Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

7.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.

Authors:  Rutger-Jan Swijnenburg; Sonja Schrepfer; Johannes A Govaert; Feng Cao; Katie Ransohoff; Ahmad Y Sheikh; Munif Haddad; Andrew J Connolly; Mark M Davis; Robert C Robbins; Joseph C Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

Review 10.  The immunogenicity of human embryonic stem-derived cells.

Authors:  Micha Drukker; Nissim Benvenisty
Journal:  Trends Biotechnol       Date:  2004-03       Impact factor: 19.536

View more
  4 in total

1.  Stem cell bioprocess engineering towards cGMP production and clinical applications.

Authors:  Sébastien Sart; Yves-Jacques Schneider; Yan Li; Spiros N Agathos
Journal:  Cytotechnology       Date:  2014-02-06       Impact factor: 2.058

Review 2.  Stem cell therapy: promising treatment in heart failure?

Authors:  John H Loughran; Atul R Chugh; Imtiaz Ismail; Roberto Bolli
Journal:  Curr Heart Fail Rep       Date:  2013-03

3.  Cell therapy in joint disorders.

Authors:  Peter D Counsel; Daniel Bates; Richard Boyd; David A Connell
Journal:  Sports Health       Date:  2015-01       Impact factor: 3.843

4.  Bone marrow-derived multipotent mesenchymal stromal cells from horses after euthanasia.

Authors:  Carmen Schröck; Carina Eydt; Florian Geburek; Lena Kaiser; Felicitas Päbst; Janina Burk; Christiane Pfarrer; Carsten Staszyk
Journal:  Vet Med Sci       Date:  2017-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.